:: Library Catalog

Image de couverture de livre

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Zhou, Junyi, Liu, Qing, Mo, May, Xia, Amy
Format:	Preprint
Publié:	2026
Sujets:	Methodology
Accès en ligne:	https://arxiv.org/abs/2605.27711
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Prediction Intervals for Interim Events in Randomized Clinical Trials with Time-to-Event Endpoints
par: Ratti, Edoardo, et autres
Publié: (2026)

A Unified Approach to Covariate Adjustment for Survival Endpoints in Randomized Clinical Trials
par: Zhang, Zhiwei, et autres
Publié: (2025)

Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials
par: Maity, Arnab Kumar, et autres
Publié: (2024)

On Cluster Randomized Trials with the Desirability of Outcome Ranking (DOOR) Endpoints
par: Shao, Wanying, et autres
Publié: (2026)

Utility-Based Dose Optimization Approaches for Multiple-Dose Randomized Trial Designs Accounting for Multiple Endpoints
par: DAngelo, Gina, et autres
Publié: (2025)

Modern Causal Inference Approaches to Improve Power for Subgroup Analysis in Randomized Controlled Trials
par: D'Alessandro, Antonio, et autres
Publié: (2025)

Study Duration Prediction for Clinical Trials with Time-to-Event Endpoints Using Mixture Distributions Accounting for Heterogeneous Population
par: Zhang, Hong, et autres
Publié: (2023)

Tipping Point Sensitivity Analysis for Missing Data in Time-to-Event Endpoints: Model-Based and Ad hoc Approaches
par: Oodally, Ajmal, et autres
Publié: (2025)

Inference for Cumulative Incidences and Treatment Effects in Randomized Controlled Trials with Time-to-Event Outcomes under ICH E9 (R1)
par: Deng, Yuhao, et autres
Publié: (2024)

Enhancing Statistical Validity and Power in Hybrid Controlled Trials: A Randomization Inference Approach with Conformal Selective Borrowing
par: Zhu, Ke, et autres
Publié: (2024)

Equal Marginal Power for Co-Primary Endpoints
par: Bond, Simon
Publié: (2026)

Power and Sample Size Calculations for Bayes Factors in two-arm clinical Phase II Trials with binary Endpoints
par: Kelter, Riko
Publié: (2026)

Data-Adaptive and Model-Robust Covariate Adjustment for Time-to-Event Outcomes in Stratified Randomized Trials
par: Kim, Raphael C., et autres
Publié: (2026)

Improving the Efficiency of Subgroup Analysis in Randomized Controlled Trials with TMLE
par: Qiu, Sky, et autres
Publié: (2026)

Adaptive Selection of the Optimal Strategy to Improve Precision and Power in Randomized Trials
par: Balzer, Laura B., et autres
Publié: (2022)

Bias in Meta-Analytic Modeling of Surrogate Endpoints in Cancer Screening Trials
par: Long, James P., et autres
Publié: (2025)

Improve Sensitivity Analysis Synthesizing Randomized Clinical Trials With Limited Overlap
par: Jiang, Kuan, et autres
Publié: (2024)

Random Forest for Dynamic Risk Prediction or Recurrent Events: A Pseudo-Observation Approach
par: Loe, Abigail, et autres
Publié: (2023)

Toward Valid Generative Clinical Trial Data with Survival Endpoints
par: Chassat, Perrine, et autres
Publié: (2025)

COADVISE: Covariate Adjustment with Variable Selection in Randomized Controlled Trials
par: Liu, Yi, et autres
Publié: (2025)

The FORSS Framework for Sample Size and Power Calculations With Win Statistics for Hierarchical Endpoints
par: Zhang, Baoshan, et autres
Publié: (2026)

A Practical Guide to Interpret a Randomized Controlled Trial
par: Tanboga, Ibrahim Halil
Publié: (2026)

M-learner:A Flexible And Powerful Framework To Study Heterogeneous Treatment Effect In Mediation Model
par: Li, Xingyu, et autres
Publié: (2025)

Model-robust Inference for Seamless II/III Trials with Covariate Adaptive Randomization
par: Yi, Kun, et autres
Publié: (2025)

Testing Prioritized Composite Endpoint with Multiple Follow-up Time Examinations
par: Mou, Yunhan, et autres
Publié: (2025)

Covariate Selection for Optimizing Balance with an Innovative Adaptive Randomization Approach
par: Guo, Ziqing, et autres
Publié: (2024)

Considerations for the Integration of Randomized Controlled Trials and Real-World Data
par: Qiu, Sky, et autres
Publié: (2026)

Notes on Randomized Controlled Trials for Studying Social Media Harms
par: Felton, Chris
Publié: (2026)

Clarifying the Role of the Mantel-Haenszel Risk Difference Estimator in Randomized Clinical Trials
par: Qiu, Xiaoyu, et autres
Publié: (2024)

Correlation Matters! Streamlining the Sample Size Procedure with Composite Time-to-event Endpoints
par: Mou, Yunhan, et autres
Publié: (2025)

Selection Bias in Hybrid Randomized Controlled Trials using External Controls: A Simulation Study
par: Chiam, Han Chang, et autres
Publié: (2025)

Privacy-preserving Quantile Treatment Effect Estimation for Randomized Controlled Trials
par: Yao, Leon, et autres
Publié: (2024)

Covariate Ordered Systematic Sampling as an Improvement to Randomized Controlled Trials
par: Jobson, Deddy, et autres
Publié: (2024)

Optimal sequential two-stage Bayes Factor Design for two-arm clinical Phase II Trials with binary Endpoints
par: Kelter, Riko
Publié: (2026)

Misclassification of Vaccination Status in Electronic Health Records: A Bayesian Approach in Cluster Randomized Trials
par: Kaplan, Adam, et autres
Publié: (2024)

Integrating Randomized Controlled Trial and External Control Data Using Balancing Weights: A Comparison of Estimands and Estimators
par: Wang, Peijin, et autres
Publié: (2025)

Complier General Causal Effect in Randomized Controlled Trials with One-Sided Noncompliance
par: Tang, Yin, et autres
Publié: (2025)

Non-collapsibility and Built-in Selection Bias of Hazard Ratio in Randomized Controlled Trials
par: Bian, Helen, et autres
Publié: (2024)

A General Form of Covariate Adjustment in Randomized Clinical Trials
par: Bannick, Marlena S., et autres
Publié: (2023)

A Surrogate Endpoint Based Provisional Approval Causal Roadmap
par: Gilbert, Peter B., et autres
Publié: (2024)